arsenic trioxide has been researched along with Carcinoma, Small Cell Lung in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KJ; Li, B; Yang, MH | 1 |
| Li, B; Shi, XQ; Wang, YS; Yang, MH; Yin, JZ; Zhao, XW | 1 |
| Chang, KJ; Jin, YX; Li, B; Yang, MH; Zhao, XW; Zheng, JC | 1 |
| Chang, KJ; Chen, WS; Li, B; Yang, MH | 1 |
| Fong, BM; Ho, JC; Lam, SK; Li, YY; Mak, JC; Zheng, CY | 1 |
| Ho, JC; Lam, SK; Li, YY; Zheng, CY | 1 |
| Bechara, R; Chen, Z; Deng, X; Khuri, FR; Kim, HS; Owonikoko, TK; Pakkala, S; Pillai, R; Ramalingam, SS; Rossi, MR; Saba, NF; Sica, GL; Stinson, RM; Sun, SY; Zhang, C; Zhang, G | 1 |
| Johansson, L; Karlsson, J; Munksgaard Persson, M; Påhlman, S; Pettersson, HM; Pietras, A; Shoshan, MC | 1 |
1 trial(s) available for arsenic trioxide and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cisplatin; Electrophoresis; Female; Humans; Lung Neoplasms; Male; Mice, SCID; Middle Aged; Neoplasm Recurrence, Local; Oxides; Small Cell Lung Carcinoma; Subcutaneous Tissue; Treatment Outcome; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2016 |
7 other study(ies) available for arsenic trioxide and Carcinoma, Small Cell Lung
| Article | Year |
|---|---|
Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplastic Stem Cells; Small Cell Lung Carcinoma | 2022 |
MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Mice; Oxides; Proto-Oncogene Proteins c-mdm2; Small Cell Lung Carcinoma; Tumor Suppressor Protein p53 | 2023 |
Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.
Topics: Animals; Arsenic Trioxide; Calcineurin; Cell Movement; Cell Proliferation; China; DNA-Binding Proteins; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Nude; Muscle Proteins; Neoplasm Metastasis; Neovascularization, Pathologic; NFATC Transcription Factors; Receptors, CXCR; rho GTP-Binding Proteins; Signal Transduction; Small Cell Lung Carcinoma; Up-Regulation; Vascular Endothelial Growth Factor A | 2019 |
Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer.
Topics: Adaptor Proteins, Signal Transducing; Angiogenesis Inhibitors; Animals; Arsenic Trioxide; Calcium-Binding Proteins; Cell Line, Tumor; Cell Proliferation; Collagen; Down-Regulation; Drug Combinations; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Laminin; Lentivirus; Lung Neoplasms; Male; Mice, Nude; Proteoglycans; Receptors, Notch; Signal Transduction; Small Cell Lung Carcinoma; Transcription Factor HES-1; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; DNA Damage; Drug Synergism; Etoposide; Female; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oxides; Reactive Oxygen Species; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2013 |
Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Cell Death; Cell Line, Tumor; DNA Damage; Glutathione; Homeostasis; Humans; Lung Neoplasms; Mitochondria; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Small Cell Lung Carcinoma; Thioredoxins | 2015 |
Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Cell Death; Cell Differentiation; Cell Hypoxia; Cell Line, Tumor; Enzyme Activation; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Oxides; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2009 |